Suomi - suomi - Fimea (Suomen lääkevirasto)

elpen pharmaceutical co. inc. - salmeterol xinafoate, fluticasone propionate - inhalaatiojauhe, annosteltu - 50 mikrog / 250 mikrog / annos - salmeteroli ja flutikasoni

Suomi - suomi - Fimea (Suomen lääkevirasto)

elpen pharmaceutical co. inc. - salmeterol xinafoate, fluticasone propionate - inhalaatiojauhe, annosteltu - 50 mikrog / 500 mikrog / annos - salmeteroli ja flutikasoni

Euroopan unioni - suomi - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - umeklidiniumbromidia - keuhkosairaus, krooninen obstruktiivinen - obstruktiivisten hengitystiesairauksien lääkkeet, - osoitettu hoidon bronkodilataattorikäsittelyksi oireiden lievittämiseksi aikuispotilailla, joilla on krooninen obstruktiivinen keuhkosairaus (copd).

Suomi - suomi - Fimea (Suomen lääkevirasto)

ratiopharm gmbh - metoprolol tartrate - tabletti - 50 mg - metoprololi

Suomi - suomi - Fimea (Suomen lääkevirasto)

ratiopharm gmbh - metoprolol tartrate - tabletti - 100 mg - metoprololi

Euroopan unioni - suomi - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate - diabetes mellitus, tyyppi 2 - diabeetilla käytettävät lääkkeet - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Suomi - suomi - Fimea (Suomen lääkevirasto)

ratiopharm gmbh - metoprololi tartras - depottabletti - 50 mg - metoprololi

Suomi - suomi - Fimea (Suomen lääkevirasto)

ratiopharm gmbh - metoprololi tartras - depottabletti - 100 mg - metoprololi

Suomi - suomi - Fimea (Suomen lääkevirasto)

ratiopharm gmbh - metoprololi tartras - depottabletti - 200 mg - metoprololi

Suomi - suomi - Fimea (Suomen lääkevirasto)

dechra veterinary products a/s - fusidic acid hemihydrate, betamethasone valerate - geeli - beetametasoni ja antibiootit